2025 Strategic Guide to the Hydrophilic Angiographic Catheters Market – Forecasts and Business Use Cases
Unlock 30% off global market reports with code ONLINE30 – get insights on tariff changes, macro trends, and global economic shifts.
What is the projected market size of the hydrophilic angiographic catheters industry, and what is its expected CAGR?
The hydrophilic angiographic catheters market size has grown strongly in recent years. It will grow from $12.6 $ billion in 2024 to $13.54 $ billion in 2025 at a compound annual growth rate (CAGR) of 7.5%. The growth in the historic period can be attributed to the growing prevalence of cardiovascular diseases, rising incidence of peripheral vascular diseases, increase in diagnostic and interventional procedures, increasing awareness and early diagnosis, and rising healthcare expenditure.
The hydrophilic angiographic catheters market size is expected to see strong growth in the next few years. It will grow to $17.88 $ billion in 2029 at a compound annual growth rate (CAGR) of 7.2%. The growth in the forecast period can be attributed to a growing aging population, a growing preference for minimally invasive procedures, a rising prevalence of diabetes, and increased funding for cardiovascular research. Major trends in the forecast period include technological advancements, expansion into emerging markets, advances in imaging technology, growing use in oncology, and focus on minimally invasive procedures.
Download Your Free Sample PDF:
What external factors are influencing the hydrophilic angiographic catheters market’s growth momentum?
The growth in the prevalence of renal disorders is expected to propel the growth of the hydrophilic angiographic catheters market going forward. Renal disorders refer to a broad category of conditions that affect the kidneys, impairing their ability to filter blood, remove waste, balance fluids and electrolytes, and regulate blood pressure. Renal disorders are growing primarily due to the increasing prevalence of risk factors such as diabetes, hypertension, and aging populations. Hydrophilic angiographic catheters are used in renal disorders for precise and smooth navigation during diagnostic and interventional procedures, such as renal artery angiography and stenting. For instance, in June 2023, according to the report published by Kidney Research UK, a UK-based non-profit organization, approximately 7.2 million people in the UK are living with chronic kidney disease, representing over 10% of the population. Of these, 3.25 million are in the advanced stages of the disease, while an additional 3.9 million are in the early stages. By 2033, the number of individuals affected by chronic kidney disease is projected to rise to 7.61 million. Therefore, the growth in the prevalence of renal disorders is driving the hydrophilic angiographic catheters market.
What are the major market segments driving the growth of the hydrophilic angiographic catheters industry?
The hydrophilic angiographic cathetersmarket covered in this report is segmented –
1) By Type: Selective Type Angiographic Catheters, Non-Selective Type Angiographic Catheters
2) By Application: Heart Disease Treatment, Kidney Disease Treatment, Other Applications
3) By End User: Hospitals, Diagnostic And Imaging Centers, Other End-Users
Subsegments:
1) By Selective Type Angiographic Catheters: Coronary Selective Catheters, Peripheral Selective Catheters, Neuro Selective Catheters
2) By Non-Selective Type Angiographic Catheters: Non-Selective Coronary Catheters, Non-Selective Peripheral Catheters, Non-Selective Neuro Catheters
View The Full Market Report:
How are emerging trends transforming the hydrophilic angiographic catheters market dynamics?
Major companies in the hydrophilic angiographic catheters market focus on developing innovative products such as catheters with various curve configurations to sustain their position in the market. Catheters with various curve configurations are specialized medical devices designed with different bending or curving shapes to navigate complex anatomical structures. For instance, in January 2024, Cook Group Incorporated, a US-based medical device company, launched its Slip-Cath Beacon Tip hydrophilic selective catheter in the USA and Canada. Designed for use in both vascular and non-vascular angiographic procedures, this catheter features over 30 different curve configurations and comes in protective foil packaging to ensure extended durability and a three-year shelf life. Its advanced technology enhances usability during procedures, and it is intended to work seamlessly with vascular access sheaths, wire guides, and various treatment devices.
Who are the key market players contributing to the growth of the hydrophilic angiographic catheters industry?
Major companies operating in the hydrophilic angiographic catheters market are Cardinal Health Inc., Abbott Laboratories, Medtronic plc, Koninklijke Philips N.V., Becton Dickinson and Company, Boston Scientific Corporation, B. Braun Melsungen AG, Terumo Corporation, Nipro Corporation, Cook Medical Inc., Teleflex Incorporated, BIOTRONIK SE & Co. KG, Lepu Medical Technology (Beijing) Co Ltd., Merit Medical Systems Inc., Cordis Corporation, MicroPort Scientific Corporation, Asahi Intecc Co Ltd., AngioDynamics Inc., Biosensors International Group Ltd., Alvimedica Medical Technologies, BrosMed Medical Co Ltd., iVascular SLU, Reva Medical Inc., Hexacath, Translumina Therapeutics LLP, Eurocor Tech GmbH, Invamed Group
Which regions are leading the growth of the hydrophilic angiographic catheters market globally?
Asia-Pacific was the largest region in the hydrophilic angiographic catheters market in 2024. The regions covered in the hydrophilic angiographic catheters market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
How Can Companies Use The Hydrophilic Angiographic Catheters Market Report to Drive Business Results?
This report provides actionable insights tailored for business use—not academic analysis. Companies can leverage the data to:
• Time market entry or expansion using growth forecasts and CAGR trends.
• Develop competitive products by tracking key technology shifts and user preferences.
• Tailor regional strategies with in-depth geographic data and local market dynamics.
• Benchmark and plan partnerships using competitive landscape insights.
Purchase The Report And Get A Swift Delivery:
Need Customized Data On Hydrophilic Angiographic Catheters Market?
For companies needing more tailored intelligence, The Business Research Company offers customized consulting and data services. Whether you're entering new regions, launching innovative products, or assessing M&A opportunities, our experts can develop actionable insights specific to your business objectives.
Request Customized Data:
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Americas +1 310-496-7795
Asia +44 2071930708
Europe +44 7882 955267
Email us at info@tbrc.info
Follow Us On:
LinkedIn: The Business Research Company | LinkedIn
Comments
Post a Comment